Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Monthly News Roundup - June 2025
Dupixent Approved in the U.S. as the First Targeted Medicine to Treat Patients with Bullous Pemphigoid Dupixent (dupilumab) has been approved for the...
Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine
MONDAY, June 30, 2025 -- For adults with obesity and migraine, liraglutide reduces migraine burden, with reductions in mean monthly headache days and Migraine...
FDA Approves Benlysta Autoinjector for Pediatric Patients With Active Lupus Nephritis
MONDAY, June 30, 2025 -- The U.S. Food and Drug Administration has approved an autoinjector of Benlysta (belimumab) for subcutaneous injection in patients...
Lower Risk of Alzheimer Disease Seen for Breast Cancer Survivors
MONDAY, June 30, 2025 -- Breast cancer survivors have a lower risk of Alzheimer disease (AD) compared with cancer-free controls, according to a study published...
Close to 150,000 Pounds of Ready-to-eat Bologna Recalled Due to Mislabeling
MONDAY, June 30, 2025 — Gaiser's European Style Provisions Inc. is recalling almost 150,000 pounds of ready-to-eat bologna due to mislabeling. The...
Capsule Sponge + Biomarkers Can Stratify Risk in Barrett Esophagus
MONDAY, June 30, 2025 -- In adult patients with nondysplastic Barrett esophagus at last endoscopy, a subsequent capsule-sponge test can assist in identifying...
Experts Sound Alarm About Risk of Child Deaths in Hot Cars
MONDAY, June 30, 2025 — With early summer temperatures already setting triple-digit records across the East Coast, safety experts are sounding the alarm...
Late-Life Mood Disorders May Indicate Predisposition to Dementia
MONDAY, June 30, 2025 -- Alzheimer disease (AD) and diverse non-AD tau pathologies may contribute to late-life mood disorders (LLMDs), according to a study...
Nestle, Other Food Companies Vow to Ban Artificial Colors
MONDAY, June 30, 2025 — Nestle has joined a growing list of major food companies pledging to voluntarily eliminate artificial colors from their U.S...
'Pill-On-A-String' Could Revolutionize Testing For Throat Cancer
MONDAY, June 30, 2025 — The thought of swallowing a pill on a thread isn’t the most pleasant notion, but it could be a vastly better alternative...
Unicycive Therapeutics Announces Receipt of Complete Response Letter for Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
LOS ALTOS, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (“Unicycive” or the “Company”) (Nasdaq: UNCY), a...
FDA Approves Gamifant (emapalumab-lzsg) as First-Ever Treatment for Adults and Children with Macrophage Activation Syndrome in Still's Disease
June 28, 2025 -- Sobi today announced that the U.S. Food and Drug Administration (FDA) approved Gamifant (emapalumab-lzsg) for the treatment of adult and...
U.S. Food and Drug Administration Approves Streamlined Patient Monitoring Requirements and Removal of REMS Programs within Bristol Myers Squibb’s Cell Therapy Labels for Breyanzi and Abecma
PRINCETON, N.J.--(BUSINESS WIRE) June 26, 2025 -- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has...
Achieve Life Sciences Announces Submission of NDA to FDA for Cytisinicline as a Treatment of Nicotine Dependence for Smoking Cessation
SEATTLE and VANCOUVER, British Columbia, June 26, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage specialty pharmaceutical...
Emmaus Life Sciences Receives FDA Approval for Endari Label Enhancements
Torrance CA, June 26, 2025 - Emmaus Life Sciences, Inc. (OTCQB: EMMA), a leader in sickle cell disease treatment, announced today that it has received Food and...
FDA Approves Benlysta (belimumab) Autoinjector for Children with Active Lupus Nephritis
Philadelphia, PA June 24 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has approved a 200 mg/mL autoinjector...
FDA Approves Expanded Indications for GE HealthCare’s Vizamyl PET Imaging Agent for Beta Amyloid Detection, Enabling More Precise Care for Alzheimer’s Patients
ARLINGTON HEIGHTS, Ill.--(BUSINESS WIRE)--Jun. 24, 2025-- GE HealthCare (Nasdaq: GEHC) today announced that the U.S. Food and Drug Administration (FDA) has...
Aldeyra Therapeutics Resubmits Reproxalap New Drug Application for the Treatment of Dry Eye Disease
LEXINGTON, Mass.--(BUSINESS WIRE)--Jun. 17, 2025-- Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and...
KalVista Pharmaceuticals Announces FDA Will Not Meet PDUFA Goal Date for Sebetralstat NDA for Hereditary Angioedema Due to FDA Resource Constraints
CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--Jun. 13, 2025-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that the U.S. Food...
Tenpoint Therapeutics Ltd. Announces FDA Acceptance of New Drug Application for Brimochol PF for the Treatment of Presbyopia
LONDON, United Kingdom and SEATTLE, Wash., June 03, 2025 – Tenpoint Therapeutics, Ltd. (“Tenpoint”), a global, clinical-stage biotechnology...
Amgen Announces Positive Topline Phase 3 Results for Bemarituzumab in Fibroblast Growth Factor Receptor 2b (FGFR2b) Positive First-line Gastric Cancer
THOUSAND OAKS, Calif., June 30, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line...
Breast Cancer Risk in Younger Women May Be Influenced by Hormone Therapy
June 30, 2025 -- Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in...
UCB Announces Positive Results from GEMZ Phase 3 Study of Fenfluramine in CDKL5 Deficiency Disorder
Brussels, Belgium – 27th June 2025 – UCB, a global biopharmaceutical company, today announced that the phase 3 study investigating the safety...
Riliprubart Earns Orphan Drug Designation in the US for Antibody-Mediated Rejection in Solid Organ Transplantation
Paris, June 25, 2025. The US Food and Drug Administration (FDA) has granted orphan drug designation to riliprubart for the investigational treatment of...
Nuvalent Announces Positive Pivotal Data from ARROS-1 Clinical Trial of Zidesamtinib for TKI Pre-treated Patients with Advanced ROS1-Positive NSCLC
CAMBRIDGE, Mass., June 24, 2025 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating precisely...
Browse by news type
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Clinical Trial Results
- Generic Drug Approvals
- Drug Shortages
Drugs.com Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
Disclaimer
This library contains syndicated news articles. These articles have not been peer-reviewed by Drugs.com, and therefore we cannot guarantee accuracy to the highest ethical standards. Do further research as needed. Consultation with your physician is essential.